← vista completa

Published on April 1, 2009 | http://doi.org/10.5867/medwave.2009.04.3853

Management of comorbidities in obesity II: dyslipidemia, fatty liver, sleep apnea, heart disease

Manejo de comorbilidades en la obesidad II: dislipidemia, hígado graso, apnea del sueño, cardiopatía

Robert Eckel

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Robert Eckel

School of Medicine, University of Colorado, Denver, Estados Unidos

Figures

Article has no figures.

Forum

No messages

History

Citation Eckel R. Management of comorbidities in obesity II: dyslipidemia, fatty liver, sleep apnea, heart disease. Medwave 2009;9(04):e3853 doi: 10.5867/medwave.2009.04.3853

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/04/2009

Index

Metrics

Not available at the moment.

Notes

References

  1. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004 Jul 13;110(2):227-39. | CrossRef | PubMed
  2. Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007 Jun;30(6):1374-83. Epub 2007 Mar 15. | CrossRef | PubMed
  3. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003 May;37(5):1202-19. | CrossRef | PubMed
  4. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002 Mar;34(3):255-62. | CrossRef | PubMed
  5. Abrams GA, Kunde SS, Lazenby AJ, Clements RH. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology. 2004 Aug;40(2):475-83. | CrossRef | PubMed
  6. Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician. 2007 May;53(5):857-63. | PubMed
  7. Harrison SA, Fincke C, Helinski D, Torgerson S, Hayashi P. A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients. Aliment Pharmacol Ther. 2004 Sep 15;20(6):623-8. | CrossRef | PubMed
  8. Hussein O, Grosovski M, Schlesinger S, Szvalb S, Assy N. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH). Dig Dis Sci. 2007 Oct;52(10):2512-9. Epub 2007 Apr 3. | CrossRef | PubMed
  9. Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007 Apr;22(4):510-4. | CrossRef | PubMed
  10. Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1537-43. | CrossRef | PubMed
  11. Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005 May;100(5):1082-90. | CrossRef | PubMed
  12. Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2004 Mar 1;19(5):537-44. | CrossRef | PubMed
  13. Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006 Nov 30;355(22):2297-307. | CrossRef | PubMed
  14. de Sousa AG, Cercato C, Mancini MC, Halpern A. Obesity and obstructive sleep apnea-hypopnea syndrome. Obes Rev. 2008 Jul;9(4):340-54. Epub 2008 Mar 18. | CrossRef | PubMed
  15. Hernandez TL, Ballard RD, Weil KM, Shepard TY, Scherzinger AL, Stamm ER, et al. Effects of maintained weight loss on sleep dynamics and neck morphology in severely obese adults. Obesity (Silver Spring). 2009 Jan;17(1):84-91. Epub 2008 Oct 23. | CrossRef | PubMed
  16. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006 Feb 14;113(6):898-918. Epub 2005 Dec 27. | CrossRef | PubMed